CELG

Celgene Corporation News Headlines

$89.11
*  
1.28
1.46%
Get CELG Alerts
*Delayed - data as of Jul. 11, 2014 14:09 ET  -  Find a broker to begin trading CELG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CELG Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Cramer's Mad Money - Apple Is All Hype, No Buzz (9/11/13)
9/12/2013 5:41:00 AM - Seeking Alpha

Novartis And NeoStem: Developing Therapies To Extend The Quality Of Life For Heart Disease Patients
9/12/2013 3:06:00 AM - Seeking Alpha

MEI Pharma Boosts Oncology Pipeline - Analyst Blog
9/11/2013 5:45:01 PM - Zacks.com

Novartis Ties Up With Regenerex - Analyst Blog
9/10/2013 11:58:17 AM - Zacks.com

FDA Expands Celgene's Abraxane Label - Analyst Blog
9/9/2013 4:57:31 PM - Zacks.com

Celgene: Strategic Valuation For Fund Managers And Institutional Investors
9/9/2013 1:31:00 PM - Seeking Alpha

Today's Market: Market Moving News For Big Pharma, Biotech & Airlines
9/9/2013 9:26:00 AM - Seeking Alpha

Just What The Doctor Ordered For Amgen
9/6/2013 2:05:00 PM - Seeking Alpha

Data on Pomalyst Published - Analyst Blog
9/6/2013 11:40:01 AM - Zacks.com

Scientific Conferences Create Buzz And Move Biotech Stocks: Michael King
9/6/2013 11:24:00 AM - Seeking Alpha

Top-Rated Stocks In Top Funds Hold Up Well In Pullback
9/4/2013 6:07:00 PM - Investor's Business Daily

U.S.: Half-Empty Or Half-Full? Investing In Guns And Gold Vs. Biotech
9/4/2013 5:41:00 PM - Seeking Alpha

2 Biopharma Stocks You Should Be Buying This Month
9/3/2013 4:15:00 PM - Seeking Alpha

OncoGenex's Apatorsen in Phase II Study - Analyst Blog
8/28/2013 5:34:55 PM - Zacks.com

Amgen Sweetens The Bid And Secures Onyx
8/26/2013 11:55:00 AM - Investopedia

Neutral on Onyx Pharma - Analyst Blog
8/22/2013 2:30:01 PM - Zacks.com

Epizyme Wins Orphan Drug Status - Analyst Blog
8/22/2013 11:30:01 AM - Zacks.com

Beating the S&P 2-to-1
8/16/2013 11:53:46 AM - Wyatt Investment Research

Onyx Pharma Narrows Loss in Q2 - Analyst Blog
8/13/2013 8:55:00 AM - Zacks.com

Wedbush Expert Declares Money For Biotech Is Still Out There
8/9/2013 11:47:00 AM - Seeking Alpha

Sorrento Secures FDA Approval Pathway Through 505(B)(2)
8/7/2013 9:26:00 AM - Seeking Alpha

Should Traders Try To Play The Odds With Cyclacel?
8/6/2013 10:58:00 AM - Seeking Alpha

Senesco's Extreme Undervaluation Provides Multi-Bagger Opportunity
8/6/2013 10:08:00 AM - Seeking Alpha

Top Funds Pick Up Generic Drugmaker Actavis
8/5/2013 6:01:00 PM - Investor's Business Daily

6 Oncology-Focused Biotech Growth Engines: Mara Goldstein
8/2/2013 6:01:00 PM - Seeking Alpha